US Stock MarketDetailed Quotes
KTRA Kintara Therapeutics
- 0.2154
- 0.00000.00%
Close Oct 17 16:00 ET
11.99MMarket Cap-673P/E (TTM)
0.0000High0.0000Low0Volume0.0000Open0.2154Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)55.66MShares23.730052wk High-1.84P/B11.97MFloat Cap2.835052wk Low--Dividend TTM55.59MShs Float238000.0000Historical High--Div YieldTTM0.00%Amplitude2.8350Historical Low--Avg Price1Lot Size
Kintara Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 39.52%-7.18M | 4.38%-1.44M | -25.89%-2.3M | 2.04%-2.12M | 79.32%-1.32M | 41.82%-11.87M | 69.79%-1.51M | 65.02%-1.83M | 57.66%-2.16M | -25.55%-6.37M |
| Net income from continuing operations | 43.20%-8.32M | 30.31%-2.32M | 38.39%-2.01M | 70.38%-1.02M | 35.55%-2.96M | 35.36%-14.65M | 38.76%-3.34M | 39.06%-3.26M | 41.39%-3.45M | 22.96%-4.6M |
| Operating gains losses | -14.50%171K | ---- | ---- | ---- | ---- | 471.43%200K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -8.33%55K | 13.33%17K | -46.67%8K | 0.00%15K | 0.00%15K | 0.00%60K | 0.00%15K | 0.00%15K | 0.00%15K | 0.00%15K |
| Other non cash items | -99.38%20K | -114.57%-133K | -95.84%55K | -95.37%50K | 155.17%48K | 17,089.47%3.23M | 10,244.44%913K | 22,150.00%1.32M | 108,000.00%1.08M | -2,800.00%-87K |
| Change In working capital | 113.26%291K | 54.75%701K | -165.97%-508K | -458.65%-1.32M | 164.08%1.42M | -3,889.09%-2.19M | -6.21%453K | 63.13%-191K | -301.69%-237K | -5,789.74%-2.22M |
| -Change in prepaid assets | 183.97%1.12M | -233.54%-215K | -91.86%21K | 1,875.00%142K | 167.13%1.17M | -8.76%-1.33M | 171.88%161K | 180.63%258K | 98.80%-8K | -13,284.62%-1.74M |
| -Change in payables and accrued expense | 4.62%-825K | 213.70%916K | -17.82%-529K | -540.17%-1.47M | 153.03%254K | -174.12%-865K | -58.70%292K | -126.77%-449K | -137.79%-229K | -1,021.15%-479K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 39.52%-7.18M | 4.38%-1.44M | -25.89%-2.3M | 2.04%-2.12M | 79.32%-1.32M | 41.82%-11.87M | 69.79%-1.51M | 65.02%-1.83M | 57.66%-2.16M | -25.55%-6.37M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 91.38%-20K | 0 | 0 | -20K | 0 | -232K | 0 | 0 | 0 | -232K |
| Net PPE purchase and sale | 91.38%-20K | --0 | --0 | ---20K | --0 | ---232K | --0 | --0 | --0 | ---232K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 91.38%-20K | --0 | --0 | ---20K | --0 | ---232K | --0 | --0 | --0 | ---232K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 470.73%10.57M | 0 | 399,750.00%7.99M | 5,258.00%2.58M | -100.10%-2K | -91.44%1.85M | -100.03%-2K | 0.00%-2K | 70.76%-50K | -86.26%1.91M |
| Net common stock issuance | 455.75%10.58M | --0 | --8M | 5,477.08%2.58M | --0 | -91.18%1.9M | -99.46%43K | --0 | 71.60%-48K | -86.18%1.91M |
| Cash dividends paid | 25.00%-6K | --0 | 0.00%-2K | 0.00%-2K | 0.00%-2K | 0.00%-8K | 0.00%-2K | 0.00%-2K | 0.00%-2K | 0.00%-2K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---43K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 470.73%10.57M | --0 | 399,750.00%7.99M | 5,258.00%2.58M | -100.10%-2K | -91.44%1.85M | -100.03%-2K | 0.00%-2K | 70.76%-50K | -86.26%1.91M |
| Net cash flow | ||||||||||
| Beginning cash position | -86.97%1.54M | 108.57%6.35M | -86.50%658K | -96.95%216K | -86.97%1.54M | 11.80%11.78M | -65.55%3.05M | -65.34%4.87M | -63.36%7.09M | 11.80%11.78M |
| Current changes in cash | 132.93%3.37M | 4.50%-1.44M | 411.26%5.69M | 119.99%442K | 71.91%-1.32M | -924.22%-10.25M | -151.34%-1.51M | 65.00%-1.83M | 58.09%-2.21M | -153.34%-4.7M |
| End cash Position | 219.80%4.91M | 219.80%4.91M | 108.57%6.35M | -86.50%658K | -96.95%216K | -86.97%1.54M | -86.97%1.54M | -65.55%3.05M | -65.34%4.87M | -63.36%7.09M |
| Free cash flow | 40.51%-7.2M | 4.38%-1.44M | -25.89%-2.3M | 1.11%-2.14M | 80.05%-1.32M | 40.68%-12.1M | 69.79%-1.51M | 65.02%-1.83M | 57.66%-2.16M | -30.12%-6.6M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data